相似文献
1
FDA guidance on prophylactic DNA vaccines: analysis and recommendations.
Vaccine. 2010 Apr 1;28(16):2801-5. doi: 10.1016/j.vaccine.2009.11.025. Epub 2009 Nov 24.
2
Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectives.
J Biopharm Stat. 2010 Nov;20(6):1178-219. doi: 10.1080/10543406.2010.514462.
3
Drug development and FDA approval, 1938-2013.
N Engl J Med. 2014 Jun 26;370(26):e39. doi: 10.1056/NEJMp1402114.
4
Historical background of changes in FDA policy on the study and evaluation of drugs in women.
Acad Med. 1994 Sep;69(9):703-7. doi: 10.1097/00001888-199409000-00004.
5
Cancer drug approval in the United States, Europe, and Japan.
Adv Cancer Res. 2007;96:371-91. doi: 10.1016/S0065-230X(06)96012-6.
6
Pharmacometrics at FDA: evolution and impact on decisions.
Clin Pharmacol Ther. 2007 Jul;82(1):97-102. doi: 10.1038/sj.clpt.6100234. Epub 2007 May 30.
7
Rofecoxib, Merck, and the FDA.
N Engl J Med. 2004 Dec 30;351(27):2875-8; author reply 2875-8. doi: 10.1056/NEJM200412303512719.
8
Déjà Vu at the FDA.
Milbank Q. 2017 Jun;95(2):245-248. doi: 10.1111/1468-0009.12252. Epub 2017 Apr 4.
9
Failing the public health--rofecoxib, Merck, and the FDA.
N Engl J Med. 2004 Oct 21;351(17):1707-9. doi: 10.1056/NEJMp048286. Epub 2004 Oct 6.
10
The role of the fDA in cancer clinical trials.
Cancer Treat Res. 2007;132:51-109. doi: 10.1007/978-0-387-33225-3_4.
引用本文的文献
1
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations.
Front Immunol. 2025 May 14;16:1584876. doi: 10.3389/fimmu.2025.1584876. eCollection 2025.
2
A comprehensive comparison of DNA and RNA vaccines.
Adv Drug Deliv Rev. 2024 Jul;210:115340. doi: 10.1016/j.addr.2024.115340. Epub 2024 May 27.
3
Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention.
Vaccines (Basel). 2024 Mar 12;12(3):298. doi: 10.3390/vaccines12030298.
4
DNA Vaccines: Their Formulations, Engineering and Delivery.
Vaccines (Basel). 2024 Jan 11;12(1):71. doi: 10.3390/vaccines12010071.
5
Plasmid DNA for Therapeutic Applications in Cancer.
Pharmaceutics. 2022 Sep 3;14(9):1861. doi: 10.3390/pharmaceutics14091861.
6
Two bicistronic DNA vaccines against and the immune effects on flounder .
J Oceanol Limnol. 2022;40(2):786-804. doi: 10.1007/s00343-021-1092-z. Epub 2022 Jan 7.
7
Antigenic characterization of influenza and SARS-CoV-2 viruses.
Anal Bioanal Chem. 2022 Apr;414(9):2841-2881. doi: 10.1007/s00216-021-03806-6. Epub 2021 Dec 14.
8
A brief review on DNA vaccines in the era of COVID-19.
Future Virol. 2021 Nov. doi: 10.2217/fvl-2021-0170. Epub 2021 Nov 26.
9
Evaluation of transgene expression characteristics and DNA vaccination against melanoma metastasis of an intravenously injected ternary complex with biodegradable dendrigraft poly-L-lysine in mice.
Drug Deliv. 2021 Dec;28(1):542-549. doi: 10.1080/10717544.2021.1895904.
10
Nucleic acid-based therapy for coronavirus disease 2019.
Heliyon. 2020 Sep;6(9):e05007. doi: 10.1016/j.heliyon.2020.e05007. Epub 2020 Sep 19.
本文引用的文献
1
Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.
Biotechnol Adv. 2009 Jul-Aug;27(4):353-70. doi: 10.1016/j.biotechadv.2009.02.003. Epub 2009 Feb 20.
2
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.
Vaccine. 2008 Nov 25;26(50):6338-43. doi: 10.1016/j.vaccine.2008.09.026. Epub 2008 Sep 26.
3
Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.
J Infect Dis. 2008 Jun 15;197(12):1634-42. doi: 10.1086/588385.
4
Immunogenicity and efficacy of a DNA vaccine in aged mice.
J Gerontol A Biol Sci Med Sci. 1998 Jul;53(4):B281-6. doi: 10.1093/gerona/53a.4.b281.
5
Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial.
J Gen Virol. 2006 Feb;87(Pt 2):399-410. doi: 10.1099/vir.0.81379-0.
6
Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.
Vaccine. 2006 May 22;24(21):4482-9. doi: 10.1016/j.vaccine.2005.08.013. Epub 2005 Aug 18.
7
Epidermal DNA vaccine for influenza is immunogenic in humans.
Vaccine. 2006 May 22;24(21):4475-81. doi: 10.1016/j.vaccine.2005.08.012. Epub 2005 Aug 19.
8
Intramuscular plasmid DNA electrotransfer: biodistribution and degradation.
Biochim Biophys Acta. 2004 Jan 20;1676(2):138-48. doi: 10.1016/j.bbaexp.2003.11.005.
9
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation.
Gene Ther. 2004 Apr;11(8):711-21. doi: 10.1038/sj.gt.3302213.
10
Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination.
Vaccine. 2003 Nov 7;21(31):4604-8. doi: 10.1016/s0264-410x(03)00447-x.
Zotero 插件